My watch list
my.bionity.com  
Login  

3,591 Current news from the ressort products

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

Three Bay Area Businesses Earn World-Class Kudos

International Competition Honors LabVelocity and Eastly Arts for Excellence in Corporate Web Sites with Life Science Innovator Guava Technologies

03-Apr-2002

SAN FRANCISCO, Calif. — GuavaTechnologies.com was recently awarded highest honors in MerComm, Inc’s international corporate Web site competition. The Grand Award winner in the healthcare division of MerComm’s 2001 iNova awards, www.guavatechnologies.com bested 17 other industry-specific category ...

more

Bruker Daltonics Announces Six Novel Life-Science Products and Three New Bioinformatics Software Releases at PittCon 2002

21-Mar-2002

NEW ORLEANS, Mar 18, 2002 - Bruker Daltonics Inc. today announces six major product introductions for mass spectrometry-based life science systems at the 2002 PittCon. In addition, Bruker Daltonics releases significant new software capabilities for three of its bioinformatics products. All ...

more

Novartis awarded Prix Galien in France for innovative cancer therapy, Glivec®

First time award given two years in a row to same pharmaceutical company in one country; 12th Prix Galien overall for Novartis

13-Mar-2002

Basel, 12 March 2002 – Novartis has been awarded the prestigious Prix Galien in France for the second year in a row, marking the first time that the same pharmaceutical company has won this distinction for two years in succession. This is the 12th time Novartis has been awarded the Prix Galien ...

more

European Commision approves Amgen´s KINERET® for the treatment of rheumatoid arthritis

First Interleukin-1 receptor antagonist represents new way to treat RA

13-Mar-2002

THOUSAND OAKS, Calif. and LUCERNE, Switzerland, March 13, 2002 - Amgen today announced that the European Commission has approved Kineret® (anakinra) for the treatment of the signs and symptoms of rheumatoid arthritis (RA) in combination with methotrexate, in patients with an inadequate response ...

more

Cambrex and BioHeart Complete Cell Therapy Supply Agreement

12-Mar-2002

East Rutherford, NJ and Fort Lauderdale, FL - March 11, 2002 - Cambrex Corporation announced today the completion of a cell therapy supply agreement between Cambrex Corporation and privately held BioHeart, Inc. BioHeart is developing cellular-based therapies to regenerate heart muscle tissue. ...

more

MorphoSys hat US-Patentstreit gegen CAT gewonnen - 2001 Verlust begrenzt

11-Mar-2002

MARTINSRIED (dpa-AFX) - Das Biotechnologie-Unternehmen MorphoSys hat 2001 seinen Umsatz deutlich gesteigert und den Verlust begrenzt. Der Umsatz sei im abgelaufenen Geschäftsjahr auf 16,1 Millionen Euro gewachsen nach 8,5 Millionen im Vorjahr, teilte das NEMAX-50-Unternehmen am Montag in ...

more

Statoil: Prized bacteria

07-Mar-2002

The Norne licence in the Norwegian Sea and Statoil specialist Egil Sunde have jointly won the Norwegian Petroleum Directorate's improved oil recovery (IOR) prize for 2001 today, 7 March. Mr Sunde is honoured for his development of the microbial enhanced oil recovery (MEOR) method for extracting ...

more

Eppendorf Simple and Rapid Isolation of Plant RNA Using the Perfect RNA, Eukaryotic Maxi Kit

06-Mar-2002

04.03.2002 The isolation of plant RNA is a particularly challenging task. Many protocols exist for the isolation of total RNA from plants that utilize solvents such as phenol or chloroform. However, their toxicity and the resulting cumbersome disposal make alternative protocols desirable. This ...

more

Millipore Acquires Rights to Disposable Manufacturing Technology for Biopharmaceutical Production

05-Mar-2002

BEDFORD, Mass., Mar 4, 2002 -- Millipore Corporation announced it has acquired rights to new technology that enables the sterile filling of biopharmaceutical drugs in a closed, disposable system. The technology was licensed on an exclusive basis for biopharmaceutical applications from Filvek, LLC ...

more

PerkinElmer Introduces Two New Microarrays For Apoptosis And Neurobiology Applications

New Microarrays Allow Researchers to Target Specific Genes in Profiling Experiments More Cost-Effectively

27-Feb-2002

BOSTON - February 26, 2002 - PerkinElmer Life Sciences, a leading provider of technology solutions and services for drug discovery, life science research and genetic disease screening, today expanded its line of glass-based microarrays with the announcement of two new microarrays -- one for ...

more

Page 356 From 360
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE